Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Frank Nastanski

Surgery Orange, CA Medical Doctor

NPI 1295702843 CMS profile 149080

101 The City Drive South, Orange, CA 92868

Open in the dashboard

General payments

$53,854

146 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Frank Nastanski of Orange, CA is reported in the CMS Open Payments database as having received $53,854 across 146 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,420 22
2024 General $2,893 18
2023 General $19,230 23
2022 General $21,271 32
2021 General $3,629 27
2020 General $2,969 17
2019 General $444 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Frank Nastanski
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Frank Nastanski were reported at $3,420. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Frank Nastanski Surgery median Middle half National median
2019 $444 $253 $82–$1,521 $163
2020 $2,969 $131 $40–$706 $114
2021 $3,629 $168 $50–$904 $132
2022 $21,271 $224 $76–$1,218 $149
2023 $19,230 $253 $82–$1,255 $160
2024 $2,893 $279 $90–$1,381 $164
2025 $3,420 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Musculoskeletal Transplant Foundation Inc. $30,663 39 payments
  2. Edwards Lifesciences Corporation $8,025 7 payments
  3. Medline Industries, Inc. $7,705 20 payments
  4. Smith+Nephew, Inc. $1,420 22 payments
  5. Kerecis Limited $1,407 8 payments
  6. Becton, Dickinson and Company $1,100 1 payment
  7. DePuy Synthes Sales Inc. $805 22 payments
  8. Urgo Medical North America, LLC $593 7 payments
  9. Aroa Biosurgery Incorporated $543 5 payments
  10. Access Pro Medical, LLC $483 3 payments
  11. Other $1,110 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $30,480 17 payments
  2. Food and Beverage $11,806 121 payments
  3. Travel and Lodging $7,988 5 payments
  4. Honoraria $2,400 2 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,180 1 payment
Products named General payments · program years 2019–2025
  1. HemoSphere $3,250 3 payments
  2. The Swan-Ganz Catheter $1,600 1 payment
  3. MEDLINE INDUSTRIES, INC. Dermatologywound Care $922 6 payments
  4. OASIS $753 6 payments
  5. Kerecis Omega3 SurgiClose Wound Care $601 2 payments
  6. Kerecis Omega3 GraftGuide $601 2 payments
  7. VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP $593 7 payments
  8. MEDLINE INDUSTRIES, INC. Dermatologywound Care $583 5 payments
  9. Kerecis Omega3 SurgiClose Wound Care $577 1 payment
  10. Kerecis Omega3 Wound $577 1 payment
  11. Other $7,793 107 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 125 billing codes

Paid by Medicare

$426,621

Medicare's payments for the services billed

Medicare patients

256

Average age 78

Services billed

3,960

127 women, 129 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Heart failure 56%
Diabetes 54%
Ischemic heart disease 51%
Atrial fibrillation 48%
Chronic kidney disease 48%
Depression 43%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

146 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record